Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Operating Income 2011-2025 | ZTS

Zoetis annual/quarterly operating income history and growth rate from 2011 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Zoetis operating income for the quarter ending June 30, 2025 was $902M, a 15.64% increase year-over-year.
  • Zoetis operating income for the twelve months ending June 30, 2025 was $3.318B, a 14.65% increase year-over-year.
  • Zoetis annual operating income for 2024 was $3.133B, a 6.71% increase from 2023.
  • Zoetis annual operating income for 2023 was $2.936B, a 10.54% increase from 2022.
  • Zoetis annual operating income for 2022 was $2.656B, a 6.75% increase from 2021.
  
Zoetis Annual Operating Income
(Millions of US $)
2024 $3,133
2023 $2,936
2022 $2,656
2021 $2,488
2020 $1,996
2019 $1,801
2018 $1,690
2017 $1,525
2016 $1,228
2015 $545
2014 $820
2013 $690
2012 $710
2011 $394
2010 $178
Zoetis Quarterly Operating Income
(Millions of US $)
2025-06-30 $902
2025-03-31 $810
2024-12-31 $732
2024-09-30 $874
2024-06-30 $780
2024-03-31 $747
2023-12-31 $650
2023-09-30 $717
2023-06-30 $872
2023-03-31 $697
2022-12-31 $592
2022-09-30 $667
2022-06-30 $670
2022-03-31 $727
2021-12-31 $506
2021-09-30 $659
2021-06-30 $636
2021-03-31 $687
2020-12-31 $420
2020-09-30 $597
2020-06-30 $482
2020-03-31 $497
2019-12-31 $437
2019-09-30 $528
2019-06-30 $455
2019-03-31 $381
2018-12-31 $418
2018-09-30 $418
2018-06-30 $437
2018-03-31 $417
2017-12-31 $430
2017-09-30 $413
2017-06-30 $345
2017-03-31 $337
2016-12-31 $231
2016-09-30 $333
2016-06-30 $332
2016-03-31 $332
2015-12-31 $69
2015-09-30 $273
2015-06-30 $-27
2015-03-31 $230
2014-12-31 $155
2014-09-30 $238
2014-06-30 $200
2014-03-31 $227
2013-12-31 $126
2013-09-30 $185
2013-06-30 $187
2013-03-31 $192
2012-12-31 $82
2012-09-30 $213
2012-06-30 $252
2012-03-31 $171
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $68.990B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $72.337B 27.82
Daiichi Sankyo, - (DSNKY) Japan $51.110B 26.19
Takeda Pharmaceutical (TAK) Japan $48.365B 9.87
BeOne Medicines - (ONC) Switzerland $34.251B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.677B 0.00
Summit Therapeutics (SMMT) United States $18.831B 0.00
Merck (MKKGY) Germany $16.743B 10.89
Shionogi (SGIOY) Japan $15.067B 15.10
United Therapeutics (UTHR) United States $14.128B 12.23
Neurocrine Biosciences (NBIX) United States $13.172B 39.29
Orion OYJ (ORINY) Finland $11.248B 27.11
IPSEN (IPSEY) France $11.218B 0.00
Eisai (ESAIY) $9.356B 10.55
Madrigal Pharmaceuticals (MDGL) United States $8.427B 0.00
Corcept Therapeutics (CORT) United States $7.396B 62.12
Grifols, S.A (GRFS) Spain $7.006B 0.00
Stevanato Group S.p.A (STVN) Italy $6.799B 40.09
Ionis Pharmaceuticals (IONS) United States $6.771B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.355B 18.39
Soleno Therapeutics (SLNO) United States $3.551B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.930B 13.93
Crinetics Pharmaceuticals (CRNX) United States $2.772B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.754B 0.00
Hypermarcas (HYPMY) Brazil $2.678B 20.13
Catalyst Pharmaceuticals (CPRX) United States $2.478B 8.30
Centessa Pharmaceuticals (CNTA) United Kingdom $2.322B 0.00
Ocular Therapeutix (OCUL) United States $2.112B 0.00
Dyne Therapeutics (DYN) United States $1.743B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.738B 0.00
Guardian Pharmacy Services (GRDN) United States $1.607B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.584B 23.59
Harrow (HROW) United States $1.415B 0.00
Ardelyx (ARDX) United States $1.412B 0.00
ARS Pharmaceuticals (SPRY) United States $1.363B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.330B 0.00
Evotec AG (EVO) Germany $1.282B 0.00
Xeris Biopharma Holdings (XERS) United States $1.188B 0.00
Collegium Pharmaceutical (COLL) United States $1.185B 6.48
Enliven Therapeutics (ELVN) United States $1.170B 0.00
Cronos Group (CRON) Canada $0.950B 0.00
Akebia Therapeutics (AKBA) United States $0.806B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.698B 7.20
Amylyx Pharmaceuticals (AMLX) United States $0.697B 0.00
ProKidney (PROK) United States $0.682B 0.00
Theravance Biopharma (TBPH) United States $0.677B 56.04
KalVista Pharmaceuticals (KALV) United States $0.640B 0.00
Siga Technologies (SIGA) United States $0.628B 7.76
Elite Pharmaceuticals (ELTP) United States $0.611B 0.00
Bioventus (BVS) United States $0.605B 14.64
Relay Therapeutics (RLAY) United States $0.586B 0.00
Tourmaline Bio (TRML) United States $0.575B 0.00
Organogenesis (ORGO) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.566B 11.59
Oruka Therapeutics (ORKA) United States $0.545B 0.00
Xencor (XNCR) United States $0.541B 0.00
Savara (SVRA) United States $0.527B 0.00
Nektar Therapeutics (NKTR) United States $0.508B 0.00
Zevra Therapeutics (ZVRA) United States $0.506B 0.00
Nanobiotix S.A (NBTX) France $0.431B 0.00
Esperion Therapeutics (ESPR) United States $0.411B 0.00
Aquestive Therapeutics (AQST) United States $0.384B 0.00
Aldeyra Therapeutics (ALDX) United States $0.335B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.320B 0.00
Altimmune (ALT) United States $0.319B 0.00
4D Molecular Therapeutics (FDMT) United States $0.307B 0.00
Larimar Therapeutics (LRMR) United States $0.302B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 19.32
AleAnna (ANNA) United States $0.268B 0.00
OmniAb (OABI) United States $0.248B 0.00
Galectin Therapeutics (GALT) United States $0.240B 0.00
Lyell Immunopharma (LYEL) United States $0.208B 0.00
Heron Therapeutics (HRTX) United States $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.194B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.181B 0.00
Korro Bio (KRRO) United States $0.180B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.173B 26.75
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
Lexeo Therapeutics (LXEO) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.151B 0.00
Profound Medical (PROF) Canada $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.131B 0.00
Avita Medical (RCEL) United States $0.130B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Avalo Therapeutics (AVTX) United States $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
Cassava Sciences (SAVA) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 23.81
Liminatus Pharma (LIMN) United States $0.100B 0.00
Surrozen (SRZN) United States $0.095B 0.00
Cardiol Therapeutics (CRDL) Canada $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.090B 0.00
BioNxt Solutions (BNXTF) Canada $0.089B 0.00
Dominari Holdings (DOMH) United States $0.085B 0.00
VAXART, INC (VXRT) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.076B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.069B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Gain Therapeutics (GANX) United States $0.061B 0.00
DURECT (DRRX) United States $0.058B 0.00
Inotiv (NOTV) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Karyopharm Therapeutics (KPTI) United States $0.054B 0.00
Rafael Holdings (RFL) United States $0.052B 0.00
Unicycive Therapeutics (UNCY) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.051B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 28.00
FibroGen (FGEN) United States $0.043B 0.00
Jupiter Neurosciences (JUNS) United States $0.043B 0.00
Tempest Therapeutics (TPST) United States $0.041B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.033B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Mural Oncology (MURA) Ireland $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.027B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.025B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Scienture Holdings (SCNX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.011B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Carisma Therapeutics (CARM) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.02
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
PainReform (PRFX) Israel $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.19
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.55
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00